Yeast Infection Market 2021- Size, Share, Opportunity, Comprehensive Analysis and Industry Demand by 2023by
Research Reports
Jan 05, 2021
Yeast Infections Market Analysis
The yeast infection market is predicted to grow at a 5.2% CAGR over the forecast period (2017-2023), states the new Market Research Future (MRFR) report. Yeast infection which is popularly known as candidiasis is a form of infection that results from different forms of yeast known as Candida. Such yeasts are generally present in the intestine, the vagina, and on the skin.
Get Free Sample Copy of “COVID-19 Pandemic Impact on Yeast Infections Market Analysis @ https://www.marketresearchfuture.com/sample_request/4228
Under normal conditions, this yeast will not cause any infection, yet at times can lead to an infection in the skin, vagina, or mouth owing to several factors of which the most common include a conducive environment, unhygienic conditions, weak immune response, amid others. Along with infants, those suffering from inflammatory disorders, hypothyroidism, obesity, and diabetes are susceptible to catching this infection. Yeast infection is most common in those areas of the skin that are humid.
Various factors are propelling the yeast infection market growth. Some of these factors according to the Market Research Future (MRFR) report, include rising incidence of autoimmune diseases, rising geriatric population, rising cases of HIV, government support for R&D, and growing demand for antifungal drugs. Additional factors pushing market growth include growing prevalence of infections, the widespread use of antibiotics, growing awareness, availability of new treatment and medications, technological advancements in medical science, pollution and unhealthy lifestyle, and increasing investments made in research and development activities.
On the contrary, side effects associated to the treatment, complications during treatments, drug resistance, and unmet clinical needs are factors that are likely to impede the yeast infection market growth over the forecast period.
Yeast Infections Market Segmentation
The MRFR report provides a complete segmental analysis of the yeast infection market on the basis of end users, treatment, types, and pathogen.
Based on pathogen, the yeast infection market is segmented into candid rugosa, candida glabrata, candida albicans, and others.
Based on type, the yeast infection market is segmented into throat yeast infection, skin yeast infection, vaginal skin infection, and others.
Based on treatment, the yeast infection market is segmented into surgery and drug treatment. The drug treatment segment is further segmented into suppository, tablet, ointment, and cream.
Based on end users, the yeast infection market is segmented into ambulatory centers, clinics, hospitals, and others.
Yeast Infections Market Regional Analysis
By region, the yeast infection market report covers the latest trends and growth opportunities across Europe, the Americas, the Asia Pacific, and the Middle East and Africa. Of these, the Americas will spearhead the market over the forecast period. This is due to the rising cases of patients suffering from immune diseases and the presence of a vast geriatric population.
The yeast infection market in Europe is predicted to have the second-largest share over the forecast period. This is chiefly due to the accessibility of government support for R&D and the availability of modern treatment facilities.
The yeast infection market in the APAC region is predicted to have a notable growth over the forecast period. This is owing to the growing prevalence of HIV in the region, growing awareness about yeast infections and the accessibility of new treatment methods. China, as well as India, are the key contributors in this region.
The yeast infection market in the Middle East and Africa is predicted to have minimal growth over the forecast period. This is owing to a lack of awareness and limited availability and access to treatment facilities.
Yeast Infections Market Key Players
Leading players profiled in the yeast infection market report include AstraZeneca (UK), ALLERGAN (Ireland), Sanofi (France), Pfizer Inc. (US), Novartis AG (Switzerland), Abbott (US), Mentis Pharma Ltd. (India), Bayer AG (Germany), Astellas (Japan), Merck & Co., Inc. (US), Synmedic Laboratories (India), and Scynexis (US).
March 2019: SCYNEXIS Inc, a leading biotech company recently revealed that a Phase 3 program is ongoing for evaluating an oral formulation to treat an acute form of vaginal yeast infection. The company is predicting the submission of this new drug application with the Food and Drug Administration (FDA), by the end of 2020.
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/yeast-infection-market-4228
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Tags:
, Reportedtimes, Research Newswire, English
YOU MAY ALSO LIKE
PW Consulting Releases Comprehensive Market Research on…
Yeast Infections Market Analysis The yeast infection market is predicted to grow at a 5.2% CAGR over the forecast period (2017-2023), states the new Market Research…
read more